{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:34:51Z","timestamp":1788910491042,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1023\/a:1007551927177","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T05:04:10Z","timestamp":1040533450000},"page":"974-977","source":"Crossref","is-referenced-by-count":28,"title":["Effects of pH and Dose on Nasal Absorption of Scopolamine Hydrobromide in Human Subjects"],"prefix":"10.1007","volume":"17","author":[{"given":"Shamim","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Sileno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge C.","family":"deMeireles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramneik","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish K.","family":"Pimplaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei J.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Langenback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Putcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent D.","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan R.","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"228632_CR1","unstructured":"American Hospital Formulatory Service (AHFS) 95 Drug Information. American Society of Health-System Pharmacists, Inc., Bethesda, MD, 1995, pp. 801\u2013804."},{"key":"228632_CR2","first-page":"171","volume":"50","author":"A. Garybiel","year":"1979","unstructured":"A. Garybiel. Prevention and treatment of space sickness in shuttleorbiter missions. Aviat. Space Environ. Med.\n50:171\u2013176 (1979).","journal-title":"Aviat. Space Environ. Med."},{"key":"228632_CR3","first-page":"131","volume":"39","author":"C. D. Wood","year":"1968","unstructured":"C. D. Wood and A. Garybiel. Evaluation of 16 anti-motion sickness drugs under controlled laboratory conditions. Aerospace Med.\n39:131\u2013134 (1968).","journal-title":"Aerospace Med."},{"key":"228632_CR4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3181\/00379727-90-22131","volume":"90","author":"H. I. Chinn","year":"1955","unstructured":"H. I. Chinn, R. W. Hyde, and J. R. Milch. Prevention and treatment of motion sickness by intranasal medication. Proc. Soc. Exp. Biol. Med.\n90:666\u2013669 (1955).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"228632_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1015916423156","volume":"6","author":"L. Putcha","year":"1989","unstructured":"L. Putcha, N. M. Cintron, J. Tsui, J. M. Vanderploeg, and W. G. Kramer. Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. Pharm. Res.\n6:481\u2013485 (1989).","journal-title":"Pharm. Res."},{"key":"228632_CR6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jps.2600760413","volume":"76","author":"N. M. Cintron","year":"1987","unstructured":"N. M. Cintron and Y. A. Chen. A sensitive radioreceptor assay for determining scopolamine concentrations in plasma. J. Pharm. Sci.\n76:328\u2013332 (1987).","journal-title":"J. Pharm. Sci."},{"key":"228632_CR7","first-page":"208","volume":"2","author":"J. Shaw","year":"1980","unstructured":"J. Shaw and J. Urquhart. Programmed systemic delivery by the transdermal route. Trends Pharmacol. Sci.\n2:208\u2013211 (1980).","journal-title":"Trends Pharmacol. Sci."},{"key":"228632_CR8","first-page":"67","volume-title":"Critical Reviews in Therapeutic Drug Career Systems","author":"Y. W. Chien","year":"1987","unstructured":"Y. W. Chien and S. F. Chang. Intranasal drug delivery for systematic medications. In S. D. Bruck (ed), Critical Reviews in Therapeutic Drug Career Systems, CRC Press Inc., Boca Raton FL, 1987, pp. 67\u2013194."},{"key":"228632_CR9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/000348945306200302","volume":"62","author":"J. Tonndorf","year":"1953","unstructured":"J. Tonndorf, H. I. Chinn, and J. E. Lett. Absorption from nasal mucous membrane: Systemic effect of hyoscine following intranasal administration. Ann. Otol., Rhinol., Laryngol.\n62:630\u2013641 (1953).","journal-title":"Ann. Otol., Rhinol., Laryngol."},{"key":"228632_CR10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/000348945306200403","volume":"62","author":"R. W. Hyde","year":"1953","unstructured":"R. W. Hyde, J. Tonndorf, and H. E. Chinn. Absorption from the nasal mucous membrane. Ann. Otol., Rhinol., Laryngol.\n62:957\u2013968 (1953).","journal-title":"Ann. Otol., Rhinol., Laryngol."},{"key":"228632_CR11","doi-asserted-by":"crossref","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M. Gibaldi","year":"1982","unstructured":"M. Gibaldi and D. Perrier. Pharmacokinetics, 2nd ed., Marcel Dekker, New York (1982).","edition":"2nd ed."},{"key":"228632_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1011952804479","volume":"15","author":"S. Kagatani","year":"1998","unstructured":"S. Kagatani, N. Inaba, M. Fukui, and T. Sonobe. Nasal absorption kinetic behavior azetirelin and its enhancement by acylcarnitines in rats. Pharm. Res.\n15:77\u201381 (1998).","journal-title":"Pharm. Res."},{"key":"228632_CR13","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1248\/bpb.19.1490","volume":"19","author":"H. Nomura","year":"1996","unstructured":"H. Nomura, S. Akamisaka, and K. Maruyama. Effects of dosing solution on the nasal absorption of non-glycosylated recombinant human granulocyte colony-stimulating factor in rats. Biol. Pharm. Bull.\n19:1490\u20131493 (1996).","journal-title":"Biol. Pharm. Bull."},{"key":"228632_CR14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1248\/bpb.18.734","volume":"18","author":"N. Shimoda","year":"1995","unstructured":"N. Shimoda, Y. Maitani, Y. Machida, and T. Nagai. Effects of dose, pH, and osmolarity on intranasal absorption of recombinant human erythropoetin in rats. Biol. Pharm. Bull.\n18:734\u2013739 (1995).","journal-title":"Biol. Pharm. Bull."},{"key":"228632_CR15","first-page":"121","volume-title":"Transnasal Systemic Medications","author":"A. A. Hussain","year":"1985","unstructured":"A. A. Hussain, R. Bawarshi-Nasar, and C. H. Huang. Physicochemical considerations in intranasal drug administrations. In Y. W. Chien (ed), Transnasal Systemic Medications, Elsevier, Amsterdam, 1985, pp. 121\u2013137."},{"key":"228632_CR16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/jps.2600740511","volume":"74","author":"T. Ohwaki","year":"1984","unstructured":"T. Ohwaki, H. Ando, S. Watanabe, and Y. Miyake. Effects of dose, pH, and osmolarity on nasal absorption of secretin. J. Pharm. Sci.\n74:550\u2013552 (1984).","journal-title":"J. Pharm. Sci."},{"key":"228632_CR17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2337\/diab.27.3.296","volume":"27","author":"S. Hirai","year":"1978","unstructured":"S. Hirai, T. Ikenaga, and T. Maatsuzawa. Nasal absorption of insulin in dogs. Diabates. 27:296\u2013299 (1978).","journal-title":"Diabates"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007551927177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007551927177\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007551927177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:39:34Z","timestamp":1754033974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007551927177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["228632"],"URL":"https:\/\/doi.org\/10.1023\/a:1007551927177","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}